Actively Recruiting

Age: 18Years +
All Genders
ID06626399

Evaluation of ChatGPT-4 for the Detection of Surgical Site Infections From Electronic Health Records After Colorectal Surgery: A Diagnostic Accuracy Study

Led by Hospital de Granollers · Updated on 2025-08-15

1100

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate how well ChatGPT-4 can detect surgical site infections (SSI) at three anatomical levels using electronic health records from patients who have had colorectal surgery. Surgical site infections are a common healthcare-associated infection that affects patient health and healthcare systems. Current surveillance methods are manual and time-consuming, and this study explores using artificial intelligence to improve detection accuracy. The study compares two methods of SSI detection for patients undergoing elective colorectal surgery: the standard manual surveillance performed by infection control teams and an automated approach using OpenAI's ChatGPT-4 chatbot trained with CDC criteria. The comparison is retrospective, using data from a nationwide infection surveillance program as the gold standard. Participants' surgical records and infection status will be analyzed to measure the rate of surgical site infections within 30 days after surgery. The study involves reviewing clinical course texts, microbiology reports, and diagnostic codes to assess AI's accuracy. The evaluation focuses on how well ChatGPT-4 identifies SSIs compared to manual methods, aiming to inform future surveillance improvements.

CONDITIONS

Brief Title

ChatGPT-4 for Surgical Site Infection Detection From Electronic Health Records After Colorectal Surgery.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Elective colorectal resection
Not Eligible

You will not qualify if you...

  • Emergency surgery
  • Infection present at operation
  • Previous intestinal stoma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 30 days

Participants undergo assessment for surgical site infections using manual surveillance and AI chatbot methods based on electronic health records after colorectal surgery.

Continuous monitoring through medical record review

Long-term Monitoring

Duration - Up to 30 days post-surgery

Participants are observed for surgical site infection outcomes up to 30 days post-surgery to ensure comprehensive detection of infections.

Ongoing observation without additional visits

Trial Site Locations

Total: 1 location

1

Hospital General de Granollers

Granollers, Barcelona, Spain, 08402

Actively Recruiting

Loading map...

Research Team

J

Josep Badia, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Randomized Control Trial Evaluating the Efficacy of Xperie...

Surgical Site Infection

Actively Recruiting

1 location

A Novel AI Algorithm With Enhanced Accuracy for Surveillance...

Surgical Site Infection

Actively Recruiting

1 location

Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected ...

Surgical Site Infection

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Validation of ChatGPT-4o for detecting surgical site infections after colorectal surgery from electronic health records: A large-scale diagnostic accuracy study.

Daniel Casanova-Portolés, Josep M Badia, Carlos G Forero...

https://pubmed.ncbi.nlm.nih.gov/41967571